Pediatric disorders of water balance.

Management of diabetes insipidus in children. Indian J Endocrinol Metab (2011) 0.75

The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med (1967) 8.08

Nephrogenic syndrome of inappropriate antidiuresis. N Engl J Med (2005) 3.83

Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med (2007) 3.22

Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J Clin Invest (2000) 2.78

Nephrogenic diabetes insipidus. Annu Rev Physiol (2001) 2.38

Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol (2005) 2.14

Central diabetes insipidus in children and young adults. N Engl J Med (2000) 1.97

Pharmacological chaperone action on G-protein-coupled receptors. Curr Opin Pharmacol (2004) 1.45

Treatment of diabetes insipidus with hydrochlorothiazide. Lancet (1959) 1.43

Antidiuretic hormone. Normal and disordered function. Endocrinol Metab Clin North Am (2001) 1.40

The syndrome of inappropriate antidiuretic hormone secretion. Int J Biochem Cell Biol (2003) 1.35

Clinical presentation and follow-up of 30 patients with congenital nephrogenic diabetes insipidus. J Am Soc Nephrol (1999) 1.33

AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance. J Cell Physiol (2008) 1.33

Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus. Am J Hum Genet (1994) 1.30

Molecular and cellular defects in nephrogenic diabetes insipidus. Pediatr Nephrol (2001) 1.14

Diabetes insipidus. Arch Dis Child (1998) 1.11

Idiopathic hypothalamic diabetes insipidus, pituitary stalk thickening, and the occult intracranial germinoma in children and adolescents. J Clin Endocrinol Metab (1997) 1.06

Functional characterization of the molecular defects causing nephrogenic diabetes insipidus in eight families. J Clin Endocrinol Metab (2000) 1.04

The diagnosis of children with central diabetes insipidus. J Pediatr Endocrinol Metab (2007) 1.02

Persistent high MR signal of the posterior pituitary gland in central diabetes insipidus. AJNR Am J Neuroradiol (1997) 1.02

Oral urea for the treatment of chronic syndrome of inappropriate antidiuresis in children. J Pediatr (2006) 1.01

Renal aquaporin water channels: from molecules to human disease. Prog Biophys Mol Biol (2003) 0.99

Functional characterization of five V2 vasopressin receptor gene mutations. Mol Cell Endocrinol (1996) 0.97

Osmoregulation of vasopressin secretion and thirst in health and disease. Clin Endocrinol (Oxf) (1988) 0.97

Posterior lobe of the pituitary in diabetes insipidus: MR findings. J Comput Assist Tomogr (1987) 0.95

Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands. Prog Brain Res (2002) 0.91

Identification, characterization and rescue of a novel vasopressin-2 receptor mutation causing nephrogenic diabetes insipidus. Clin Endocrinol (Oxf) (2008) 0.90

Frequency and variation of the posterior pituitary bright signal on MR images. AJNR Am J Neuroradiol (1989) 0.88

Hydrochlorothiazide-amiloride in the treatment of congenital nephrogenic diabetes insipidus. Am J Nephrol (1985) 0.85

Amiloride-hydrochlorothiazide versus indomethacin-hydrochlorothiazide in the treatment of nephrogenic diabetes insipidus. J Pediatr (1990) 0.85

Utility of magnetic resonance imaging in the evaluation of the child with central diabetes insipidus. J Pediatr Endocrinol Metab (2002) 0.83

Molecular genetics of familial central diabetes insipidus. J Clin Endocrinol Metab (1993) 0.83

Diabetes insipidus. Rev Endocr Metab Disord (2003) 0.82

Autosomal recessive familial neurohypophyseal diabetes insipidus with continued secretion of mutant weakly active vasopressin. Hum Mol Genet (1999) 0.82

Treatment of nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride. Arch Dis Child (1999) 0.81

Hyperintensity of posterior pituitary on MR T1WI in a boy with central diabetes insipidus caused by missense mutation of neurophysin II gene. Endocr J (2001) 0.80

Autosomal dominant neurohypophyseal diabetes insipidus associated with a missense mutation encoding Gly23-->Val in neurophysin II. J Clin Endocrinol Metab (1997) 0.80

Vasopressin transport regulation is coupled to the synthesis rate. Neuroendocrinology (1991) 0.79

Clinical and molecular analysis of three families with autosomal dominant neurohypophyseal diabetes insipidus associated with a novel and recurrent mutations in the vasopressin-neurophysin II gene. Eur J Endocrinol (2002) 0.79

[Magnetic resonance imaging in central diabetes insipidus in children and adolescents. findings at diagnosis and during follow-up]. An Esp Pediatr (2000) 0.78

MR imaging of the posterior hypophysis in children. AJR Am J Roentgenol (1989) 0.78

Natriuresis and atrial natriuretic factor secretion during inappropriate antidiuresis. Am J Med (1988) 0.78

Nephrogenic syndrome of inappropriate antidiuresis. N Engl J Med (2005) 3.83

Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. J Pediatr (2003) 1.36

Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes. J Clin Invest (2014) 1.22

Oral urea for the treatment of chronic syndrome of inappropriate antidiuresis in children. J Pediatr (2006) 1.01

Functional characterization of vasopressin type 2 receptor substitutions (R137H/C/L) leading to nephrogenic diabetes insipidus and nephrogenic syndrome of inappropriate antidiuresis: implications for treatments. Mol Pharmacol (2010) 1.00

Early stimulation and late inhibition of extracellular signal-regulated kinase 1/2 phosphorylation by IGF-I: a potential mechanism mediating the switch in IGF-I action on skeletal muscle cell differentiation. Endocrinology (2002) 0.99

Nephrogenic syndrome of inappropriate antidiuresis: a novel disorder in water balance in pediatric patients. Am J Med (2006) 0.91

Identification, characterization and rescue of a novel vasopressin-2 receptor mutation causing nephrogenic diabetes insipidus. Clin Endocrinol (Oxf) (2008) 0.90

Nordihydroguaiaretic acid inhibits insulin-like growth factor signaling, growth, and survival in human neuroblastoma cells. J Cell Biochem (2007) 0.86

Isolated adrenocorticotropic hormone deficiency presenting as an acute neurologic emergency in a peripubertal girl. J Pediatr Endocrinol Metab (2008) 0.84

Respiratory syncytial virus infection as a precipitant of thyroid storm in a previously undiagnosed case of graves' disease in a prepubertal girl. Int J Pediatr Endocrinol (2011) 0.83

Pediatric disorders of water balance. Pediatr Clin North Am (2011) 0.83

Child and Adolescent Gender Center: a multidisciplinary collaboration to improve the lives of gender nonconforming children and teens. Pediatr Rev (2012) 0.82

Akt phosphorylation is not sufficient for insulin-like growth factor-stimulated myogenin expression but must be accompanied by down-regulation of mitogen-activated protein kinase/extracellular signal-regulated kinase phosphorylation. Endocrinology (2004) 0.81

Research priorities for gender nonconforming/transgender youth: gender identity development and biopsychosocial outcomes. Curr Opin Endocrinol Diabetes Obes (2016) 0.78

Persistent elevation of urine aquaporin-2 during water loading in a child with nephrogenic syndrome of inappropriate antidiuresis (NSIAD) caused by a R137L mutation in the V2 vasopressin receptor. Int J Pediatr Endocrinol (2012) 0.76

Contextualized analysis of a needs assessment using the Theoretical Domains Framework: a case example in endocrinology. BMC Health Serv Res (2014) 0.75

Author's Response. Pediatrics (2015) 0.75

Statement on gender-affirmative approach to care from the pediatric endocrine society special interest group on transgender health. Curr Opin Pediatr (2017) 0.75

Report of a hürthle cell neoplasm in a peripubertal girl. Thyroid (2007) 0.75